期刊文献+

大疱性类天疱疮患者继发感染危险因素研究进展

Risk factors for secondary infection in patients with bullous pemphigoid
原文传递
导出
摘要 继发感染是导致大疱性类天疱疮患者死亡的主要原因。早期识别大疱性类天疱疮继发感染的危险因素,可改善患者预后。本文综述大疱性类天疱疮继发感染的风险与患者临床特征、实验室指标、药物治疗以及住院时间之间的相关性,以期为临床评估及指导治疗提供参考。 Secondary infection is the leading cause of death in patients with bullous pemphigoid.Early identification of risk factors for secondary infection in patients with bullous pemphigoid can improve their prognosis.This review summarizes the relationships of secondary infection in bullous pemphigoid with clinical characteristics,laboratory indicators,drug treatment,and duration of hospitalization,providing a reference for clinical evaluation and treatment.
作者 任伟琦 邹雅茹 潘敏 Ren Weiqi;Zou Yaru;Pan Min(Department of Dermatology and Venereology,the Affiliated Hospital of Qingdao University,Qingdao 266003,Shandong,China)
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2024年第8期770-772,共3页 Chinese Journal of Dermatology
基金 国家自然科学基金(82103721) 山东省自然科学基金(ZR2021QH121)。
关键词 类天疱疮 大疱性 感染 危险因素 治疗 住院时间 临床特征 Pemphigoid bullous Infection Risk factors Therapy Length of stay Clinical features
  • 相关文献

参考文献7

二级参考文献28

  • 1王娣,陈喜雪,朱学骏.124例大疱性类天疱疮治疗回顾[J].中华皮肤科杂志,2007,40(1):7-9. 被引量:31
  • 2Cho YT, Chu CY, Wang LF. First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid[J]. BrJ Dermatol, 2014 Dec 22. doi: 1O.IIII/bjd.13633.
  • 3Schulze F, Kasperkiewicz M, Zillikens D, et al. Bullous pemphigoid[J]. Hautarzt, 2013, 64(12):931-945.
  • 4KimJR, Kim sc. Epidermolysis bullosa acquisita[J].J Eur Acad Dermatol Venereol, 2013, 27(10):1204-1213.
  • 5Meurer M. Immunosuppressive therapy for autoimmune bullous diseases Pl. Clin Dermatol, 2012, 30(1):78-83.
  • 6Gual A, Iranzo P, Mascaro 1MJr. Treatment of bullous pemphigoid with low-dose oral cyclophosphamide: a case series of 20 patients[J].J Eur Acad Dermatol Venereol, 2014, 28(6):814-818.
  • 7Kjellman P, Eriksson H, Berg P. A retrospective analysis of patients with bullous pemphigoid treated with methotrexate[J]. Arch Dermatol, 2008, 144(5):612-616.
  • 8Kwatra SG,JorizzoJL. Bullous pemphigoid: a case series with emphasis on long-term remission off therapy[J].J Dermatolog Treat, 2013,24(5):327-331.
  • 9Du-Thanh A, Merlet S, Maillard H, et al. Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, muiticentre, retrospective study[J]. BrJ Dermatol, 2011,165(6):1337-1343.
  • 10Rzany B, Partscht K,Jung M, et al. Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age[J]. Arch Dermatol, 2002, 138 (7):903-908.

共引文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部